Sting Agonist, Adu-S100, Yields Potent Anti-Tumour Activity And Therapeutically Favorable Immune Profile In An Esophageal Adenocarcinoma Model A. H. Zaidi, A. N. Omstead,N. Chowdhury, J. E. Kosovec, P. Zheng, M. S. Salvitti, A. Gorbunova,L. Babar, R. J. Kelly, B. A. JobeANNALS OF ONCOLOGY（2019）引用 2|浏览23暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
